熱門資訊> 正文
scPharmaceuticals从Perceptive Advisors获得1.25亿美元资金
2024-08-12 19:08
- scPharmaceuticals (NASDAQ:SCPH) said it has entered into non-dilutive financings totaling up to $125 million with funds managed by Perceptive Advisors.
- The company said it has entered into a $75 million senior secured term loan agreement with Perceptive, and around $50 million will be provided to the company at close, which will refinance its existing debt.
- The firm has also entered into a $50 million capped revenue interest financing with Perceptive.
- Separately, SCPH said it intends to conduct a proposed underwritten public offering of shares of its common stock or, pre-funded warrants.
More on scPharmaceuticals
- scPharmaceuticals Inc. (SCPH) Q1 2024 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on scPharmaceuticals
- Historical earnings data for scPharmaceuticals
- Financial information for scPharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
